6-(2-tert-butyl-5-(6-methylpyridin-2-yl)-1H-imidazol-4-yl)quinoxaline,
SB 525334,
SB-525334,
SB525334,
356559-20-1,
SB 525334,
SB-525334,
SB525334,
6-(2-(tert-Butyl)-5-(6-methylpyridin-2-yl)-1H-imidazol-4-yl)quinoxaline,
6-[2-TERT-BUTYL-5-(6-METHYL-PYRIDIN-2-YL)-1H-IMIDAZOL-4-YL]-QUINOXALINE,
CHEMBL401570,
MFCD11045307,
6-[2-(1,1-DiMethylethyl)-5-(6-Methyl-2-pyridinyl)-1H-iMidazol-4-yl]quinoxaline,
C21H21N5,
6-(2-tert-butyl-5-(6-methylpyridin-2-yl)-1H-imidazol-4-yl)quinoxaline,
6-[2-tert-butyl-5-(6-methylpyridin-2-yl)-1H-imidazol-4-yl]quinoxaline,
MLS006011134,
SCHEMBL373474,
QCR-68,
SCHEMBL10000768,
CHEBI:91391,
CTK4H5088,
AOB5969,
EX-A256,
HMS3262O09,
HMS3654B14,
BCP02045,
KS-000000IM,
TGF-|A RI Kinase Inhibitor VIII,
Tox21_500714,
ABP000161,
ANW-71297,
BDBM50320952,
s1476,
ZINC13980772,
AKOS016008294,
AKOS024457481,
ACN-053036,
API0007587,
CCG-222018,
CS-0199,
LP00714,
RL03346,
SB19482,
NCGC00186024-01,
NCGC00186024-02,
NCGC00261399-01,
4CA-1143,
AJ-64547,
AJ-64548,
AK-99209,
AN-16887,
BC659973,
HY-12043,
SC-93926,
SMR004702912,
RT-016014,
FT-0674528,
ST24045014,
SW219430-1,
X7491,
SB 525334/SB525334,
W-5464,
SB-525334, >=98% (HPLC),
J-518186,
BRD-K37720887-001-01-1,
SB525334, SB 525334, 356559-20-1,
6-[2-t-butyl-5-(6-methyl-pyridin-2-yl)-1h-imidazol-4-yl]-quinoxaline,
6-[2-tert-butyl-5-(6-methyl-2-pyridyl)-1H-imidazol-4-yl]quinoxaline,
6-[2-tert-butyl-5-(6-methylpyridin-2-yl)-3H-imidazol-4-yl]quinoxaline,
6-[2-(TERT-BUTYL)-5-(6-METHYL-PYRIDIN-2-YL)-1H-IMIDAZOL-4-YL]QUINOXALINE,
Quinoxaline, 6-(2-(1,1-dimethylethyl)-5-(6-methyl-2-pyridinyl)-1H-imidazol-4-yl)-,
D03ANS,
cc-539,
DKPQHFZUICCZHF-UHFFFAOYSA-N,
CID9967941,
A5602,
A10827,
6-[5-(6-methylpyridin-2-yl)-2-tert-butyl-1H-imidazol-4-yl]quinoxaline,
6-[2-(1,1-Dimethylethyl)-5-(6-methyl-2-pyridinyl)-1H-imidazol-4-yl]quinoxaline;,